Literature DB >> 19745165

A role of matrix metalloproteinase-8 in atherosclerosis.

Ross C Laxton1, Yanhua Hu, Johan Duchene, Feng Zhang, Zhongyi Zhang, Kit-Yi Leung, Qingzhong Xiao, Ramona S Scotland, Conrad P Hodgkinson, Katherine Smith, Johann Willeit, Carlos López-Otín, Iain A Simpson, Stefan Kiechl, Amrita Ahluwalia, Qingbo Xu, Shu Ye.   

Abstract

RATIONALE: Atherosclerotic lesions express matrix metalloproteinase (MMP)8, which possesses proteolytic activity on matrix proteins particularly fibrillar collagens and on nonmatrix proteins such as angiotensin (Ang) I.
OBJECTIVE: We studied whether MMP8 plays a role in atherogenesis. METHODS AND
RESULTS: In atherosclerosis-prone apolipoprotein E-deficient mice, inactivating MMP8 resulted in a substantial reduction in atherosclerotic lesion formation. Immunohistochemical examinations showed that atherosclerotic lesions in MMP8-deficient mice had significantly fewer macrophages but increased collagen content. In line with results of in vitro assays showing that Ang I cleavage by MMP8 generated Ang II, MMP8 knockout mice had lower Ang II levels and lower blood pressure. In addition, we found that products of Ang I cleavage by MMP8 increased vascular cell adhesion molecule (VCAM)-1 expression and that MMP8-deficient mice had reduced VCAM-1 expression in atherosclerotic lesions. Intravital microscopy analysis showed that leukocyte rolling and adhesion on vascular endothelium was reduced in MMP8 knockout mice. Furthermore, we detected an association between MMP8 gene variation and extent of coronary atherosclerosis in patients with coronary artery disease. A relationship among MMP8 gene variation, plasma VCAM-1 level, and atherosclerosis progression was also observed in a population-based, prospective study.
CONCLUSIONS: These results indicate that MMP8 is an important player in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745165      PMCID: PMC2853782          DOI: 10.1161/CIRCRESAHA.109.200279

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  48 in total

1.  The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group.

Authors:  S Kiechl; J Willeit
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-06       Impact factor: 8.311

2.  Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

Authors:  O V Volpert; W F Ward; M W Lingen; L Chesler; D B Solt; M D Johnson; A Molteni; P J Polverini; N P Bouck
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

4.  Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study.

Authors:  Shu Ye; Johann Willeit; Florian Kronenberg; Qingbo Xu; Stefan Kiechl
Journal:  J Am Coll Cardiol       Date:  2008-07-29       Impact factor: 24.094

5.  Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation.

Authors:  J Silence; F Lupu; D Collen; H R Lijnen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

Review 6.  Matrix metalloproteinase-8: cleavage can be decisive.

Authors:  Philippe Van Lint; Claude Libert
Journal:  Cytokine Growth Factor Rev       Date:  2006-07-03       Impact factor: 7.638

7.  Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress.

Authors:  M E Pueyo; W Gonzalez; A Nicoletti; F Savoie; J F Arnal; J B Michel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

8.  Loss of collagenase-2 confers increased skin tumor susceptibility to male mice.

Authors:  Milagros Balbín; Antonio Fueyo; Angus M Tester; Alberto M Pendás; Ana S Pitiot; Aurora Astudillo; Christopher M Overall; Steven D Shapiro; Carlos López-Otín
Journal:  Nat Genet       Date:  2003-09-28       Impact factor: 38.330

9.  Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study.

Authors:  Shu Ye; Louise Dunleavey; Wendy Bannister; Lorna B Day; William Tapper; Andrew R Collins; Ian N M Day; Iain Simpson
Journal:  Eur J Hum Genet       Date:  2003-06       Impact factor: 4.246

10.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

View more
  38 in total

1.  Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Venkateswaran Subramanian; Haruhito A Uchida; Talha Ijaz; Jessica J Moorleghen; Deborah A Howatt; Anju Balakrishnan
Journal:  J Cardiovasc Pharmacol       Date:  2012-01       Impact factor: 3.105

Review 2.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

3.  Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia.

Authors:  Feng Yang; Qishan Chen; Mei Yang; Eithne Margaret Maguire; Xiaotian Yu; Shiping He; Rui Xiao; Claire S Wang; Weiwei An; Wei Wu; Yijiang Zhou; Qingzhong Xiao; Li Zhang
Journal:  Cardiovasc Res       Date:  2020-01-01       Impact factor: 10.787

4.  Arterial smooth muscle.

Authors:  Valerie Z Wall; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10       Impact factor: 8.311

5.  Vascular angiotensin-converting enzyme 2: lord of the ring?

Authors:  Daniel Batlle; Jan Wysocki; Mirza S Khan
Journal:  Circ Res       Date:  2010-10-01       Impact factor: 17.367

6.  A Novel Role of Matrix Metalloproteinase-8 in Macrophage Differentiation and Polarization.

Authors:  Guanmei Wen; Cheng Zhang; Qishan Chen; Le Anh Luong; Arif Mustafa; Shu Ye; Qingzhong Xiao
Journal:  J Biol Chem       Date:  2015-06-19       Impact factor: 5.157

Review 7.  Targeting neutrophils in ischemic stroke: translational insights from experimental studies.

Authors:  Glen C Jickling; DaZhi Liu; Bradley P Ander; Boryana Stamova; Xinhua Zhan; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-25       Impact factor: 6.200

8.  Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

Authors:  Valéria A Gomes; Carolina S Vieira; Anna L Jacob-Ferreira; Vanessa A Belo; Gustavo M Soares; Janaína B F Fernandes; Rui A Ferriani; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

9.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

10.  Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata.

Authors:  Thibaut Quillard; Haniel Alves Araújo; Gregory Franck; Yevgenia Tesmenitsky; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.